Skip to main navigation Skip to search Skip to main content

Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)398-406
JournalEuropean journal of haematology
Volume92
Issue number5
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this